December 14, 2017 5:57 AM ET


Company Overview of Evivrus, Inc.

Company Overview

Evivrus, Inc., a development-stage biopharmaceutical company, engages in the discovery and development of medicines for patients with cancer and other life-threatening conditions. Its drug development program utilizes various technologies, including its PEGylation customized linker technology and the locked nucleic acid technology. The company’s development pipeline consists of various novel product candidates comprising recombinant human mannose-binding lectin (rhMBL), a human plasma protein under the Phase I/II clinical trials for prevention and treatment of severe infection in patients with low MBL levels. It is also conducting two clinical trials with PEG-SN38 in patients with solid tumo...

20 Kingsbridge Road

Piscataway, NJ 08854

United States



Key Executives for Evivrus, Inc.

Evivrus, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Evivrus, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at